Receptors, Serotonin

"Receptors, Serotonin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action.

Descriptor ID	D011985
MeSH Number(s)	D12.776.543.750.670.800 D12.776.543.750.695.800 D12.776.543.750.720.850
Concept/Terms	Receptors, Serotonin Receptors, Serotonin 5-Hydroxytryptamine Receptors 5 Hydroxytryptamine Receptors 5-HT Receptors 5 HT Receptors Receptors, 5-HT Receptors, 5 HT Receptors, 5-Hydroxytryptamine Receptors, 5 Hydroxytryptamine Serotonin Receptors Receptors, Tryptamine Receptors, Tryptamine Tryptamine Receptors

Below are MeSH descriptors whose meaning is more general than "Receptors, Serotonin".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Membrane Proteins [D12.776.543]
Receptors, Cell Surface [D12.776.543.750]
Receptors, Biogenic Amine [D12.776.543.750.670]
Receptors, Serotonin [D12.776.543.750.670.800]
Receptors, G-Protein-Coupled [D12.776.543.750.695]
Receptors, Serotonin [D12.776.543.750.695.800]
Receptors, Neurotransmitter [D12.776.543.750.720]
Receptors, Serotonin [D12.776.543.750.720.850]

Below are MeSH descriptors whose meaning is related to "Receptors, Serotonin".

Below are MeSH descriptors whose meaning is more specific than "Receptors, Serotonin".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Receptors, Serotonin" by people in this website by year, and whether "Receptors, Serotonin" was a major or minor topic of these publications.

Bar chart showing 28 publications over 17 distinct years, with a maximum of 4 publications in 2007

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
1997	0	1	1
1998	1	1	2
1999	2	0	2
2000	2	0	2
2001	2	0	2
2002	1	1	2
2003	2	1	3
2007	2	2	4
2008	1	1	2
2009	1	0	1
2010	0	1	1
2012	0	1	1
2019	1	0	1
2020	0	1	1
2022	0	1	1
2025	0	1	1

Below are the most recent publications written about "Receptors, Serotonin" by people in Profiles.

Lam K, Peltz G, Kraft WK. The role of 5-HT modulation in opioid withdrawal and neonatal opioid withdrawal syndrome: mechanisms and potential serotonergic targets. Expert Opin Investig Drugs. 2025 Jan-Feb; 34(1-2):49-59.

View in: PubMed
Leitner DF, Devore S, Laze J, Friedman D, Mills JD, Liu Y, Janitz M, Anink JJ, Baayen JC, Idema S, van Vliet EA, Diehl B, Scott C, Thijs R, Nei M, Askenazi M, Sivathamboo S, O'Brien T, Wisniewski T, Thom M, Aronica E, Boldrini M, Devinsky O. Serotonin receptor expression in hippocampus and temporal cortex of temporal lobe epilepsy patients by postictal generalized electroencephalographic suppression duration. Epilepsia. 2022 11; 63(11):2925-2936.

View in: PubMed
Tepper SJ, Vasudeva R, Krege JH, Rathmann SS, Doty E, Vargas BB, Magis D, Komori M. Evaluation of 2-Hour Post-Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult-to-Treat Migraine Attacks. Headache. 2020 Sep; 60(8):1601-1615.

View in: PubMed
Ceriani CEJ, Wilhour DA, Silberstein SD. Novel Medications for the Treatment of Migraine. Headache. 2019 10; 59(9):1597-1608.

View in: PubMed
Silberstein SD. Emerging target-based paradigms to prevent and treat migraine. Clin Pharmacol Ther. 2013 Jan; 93(1):78-85.

View in: PubMed
Dawe GS, Nagarajah R, Albert R, Casey DE, Gross KW, Ratty AK. Antipsychotic drugs dose-dependently suppress the spontaneous hyperactivity of the chakragati mouse. Neuroscience. 2010 Nov 24; 171(1):162-72.

View in: PubMed
Bernotas RC, Lenicek S, Antane S, Cole DC, Harrison BL, Robichaud AJ, Zhang GM, Smith D, Platt B, Lin Q, Li P, Coupet J, Rosenzweig-Lipson S, Beyer CE, Schechter LE. Novel 1-aminoethyl-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines are potent 5-HT(6) agonists. Bioorg Med Chem. 2009 Jul 15; 17(14):5153-63.

View in: PubMed
Jonnakuty C, Gragnoli C. What do we know about serotonin? J Cell Physiol. 2008 Nov; 217(2):301-6.

View in: PubMed
Borgmann-Winter KE, Rawson NE, Wang HY, Wang H, Macdonald ML, Ozdener MH, Yee KK, Gomez G, Xu J, Bryant B, Adamek G, Mirza N, Pribitkin E, Hahn CG. Human olfactory epithelial cells generated in vitro express diverse neuronal characteristics. Neuroscience. 2009 Jan 23; 158(2):642-53.

View in: PubMed
Cole DC, Stock JR, Lennox WJ, Bernotas RC, Ellingboe JW, Boikess S, Coupet J, Smith DL, Leung L, Zhang GM, Feng X, Kelly MF, Galante R, Huang P, Dawson LA, Marquis K, Rosenzweig-Lipson S, Beyer CE, Schechter LE. Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonist. J Med Chem. 2007 Nov 15; 50(23):5535-8.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement